KaliVir Immunotherapeutics
Gabriella A. Acosta-Barreto is currently employed as an Immunology Laboratory Technician at KaliVir Immunotherapeutics since 2021. Prior to this, they held the role of Research Technician at the University of Pittsburgh from 2018.
Gabriella A. Acosta-Barreto attended the University of Puerto Rico, Río Piedras from 2012 to 2017, where they obtained a Bachelor's degree in Cell/Cellular and Molecular Biology. Gabriella A. then went on to pursue a Master of Science in Infectious Disease and Microbiology at the University of Pittsburgh, which they are expected to complete in 2023.
KaliVir Immunotherapeutics
KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment that engages a virus’ natural ability to replicate in and kill cancer cells